2R3 Intrinsic Valuation and Fundamental Analysis - Reata Pharmaceuticals Inc

R

Watchlist Manager

Watchlist

Price: 161 EUR

Market Cap: €6B

R	Reata Pharmaceuticals Inc F:2R3	US
	Low Keng Huat (Singapore) Ltd SGX:F1E	SG

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value for Reata Pharmaceuticals Inc.

Why combine DCF with multiples? What is Intrinsic Value?

Fundamental Analysis

Jun 2015 Sep 2015 Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023

Wall St
Price Targets

Dividends

Competitive Landscape

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.